Your session is about to expire
← Back to Search
Genetic Testing for Inherited Cancer Risk
Study Summary
This trial offers free genetic testing to the public to learn the value of testing for high risk cancer types.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am 18 years old or older.I have genetic mutations in BRCA1, BRCA2, or Lynch syndrome.I am willing to provide a DNA sample.You have received genetic counseling within the past 5 years.I may or may not have been diagnosed with cancer.I have been diagnosed with a type of cancer that is tracked by the National Cancer Institute, including early-stage breast cancer.I have genetic variants like BRCA1, BRCA2, or Lynch syndrome.I choose to provide a DNA sample.I may or may not have a cancer diagnosis.I have had genetic counseling in the last 1-2 years.I have seen a doctor or been in a hospital within the last year.
- Group 1: Screening (genetic testing)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the current total of participants in this experiment?
"Indeed, the information on clinicaltrials.gov indicates that recruitments are in progress for this trial which was initially posted by 3rd of September 2020 and lately modified on 15th of September 2022. The research requires 27500 participants from two distinct sites."
Are there opportunities for patients to participate in this experiment at present?
"Correct. According to the clinicaltrials.gov website, this medical experiment is still actively recruiting patients who meet certain criteria; it was initially published on March 9th 2020 and has since been updated as recently as September 15th 2022. A total of 27,500 participants are needed at two different sites for the trial to be successful."
Share this study with friends
Copy Link
Messenger